{"doc_id": "PMC-1472690-14-Methods-06.txt", "sent_id": "", "tokens": ["Immuno", "(", "Dot", ")", "blot"], "sentence": "Immuno ( Dot ) blot", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1472690-14-Methods-06.txt", "sent_id": "S2", "tokens": ["To", "determine", "whether", "the", "DNA", "binding", "proteins", "were", "related", "to", "NFkappaB", "and", "NFAT", ",", "dot", "blots", "using", "a", "SRC96D", "SNS", "minifold", "I", "dot", "blotter", "(", "Schleicher", "&", "Schull", ",", "Dassel", ",", "Germany", ")", "were", "performed", "with", "the", "following", "positive", "controls", "and", "antibodies", "(", "all", "from", "Santa", "Cruz", "Biotechnology", ",", "Heidelberg", ",", "Germany", ")", ":", "positive", "controls", "(", "10", "ng", "/", "dot", ")", ":", "NFkappaB", "p52", "(", "80", "kD", ")", "sc-4095WB", ",", "c-Rel", "(", "61", "kD", ")", "sc-4030WB", ";", "Jurkat", "nuclear", "extract", ",", "PMA", "-", "stimulated", ";", "primary", "antibodies", "(", "1", "mug", "/", "dot", ")", ":", "anti-NFkappaB", "p50", "(", "NLS", ")", "sc-114", ",", "anti-NFkappaB", "p65", "(", "A", ")", "sc-109", ",", "anti-NFkappaB", "p52", "(", "447", ")", "sc-848", ",", "a", "rabbit", "polyclonal", "IgG1", "antiserum", ",", "anti", "-", "c-rel", "(", "N466", ")", "sc-272", ",", "anti", "-", "NFATc2", "(", "M-20", ")", "sc-1151", ",", "anti", "-", "NFATc1", "(", "K-18", ")", "sc-1149", ",", "two", "goat", "polyclonal", "IgG1", "antisera", ";", "secondary", "antibodies", "(", "0.8", "mug", "/", "dot", ")", ":", "goat", "anti-rabbit", "IgG", "AP-conjugate", "sc-2007", ",", "and", "donkey", "anti-goat", "IgG", "AP-conjugate", "sc-2022", "."], "sentence": "To determine whether the DNA binding proteins were related to NFkappaB and NFAT , dot blots using a SRC96D SNS minifold I dot blotter ( Schleicher & Schull , Dassel , Germany ) were performed with the following positive controls and antibodies ( all from Santa Cruz Biotechnology , Heidelberg , Germany ) : positive controls ( 10 ng / dot ) : NFkappaB p52 ( 80 kD ) sc-4095WB , c-Rel ( 61 kD ) sc-4030WB ; Jurkat nuclear extract , PMA - stimulated ; primary antibodies ( 1 mug / dot ) : anti-NFkappaB p50 ( NLS ) sc-114 , anti-NFkappaB p65 ( A ) sc-109 , anti-NFkappaB p52 ( 447 ) sc-848 , a rabbit polyclonal IgG1 antiserum , anti - c-rel ( N466 ) sc-272 , anti - NFATc2 ( M-20 ) sc-1151 , anti - NFATc1 ( K-18 ) sc-1149 , two goat polyclonal IgG1 antisera ; secondary antibodies ( 0.8 mug / dot ) : goat anti-rabbit IgG AP-conjugate sc-2007 , and donkey anti-goat IgG AP-conjugate sc-2022 .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "NFAT", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T2", "text": "p52", "entity_type": "Protein", "start": 64, "end": 64}, {"id": "T3", "text": "c-Rel", "entity_type": "Protein", "start": 71, "end": 71}, {"id": "T4", "text": "p50", "entity_type": "Protein", "start": 96, "end": 96}, {"id": "T5", "text": "p65", "entity_type": "Protein", "start": 103, "end": 103}, {"id": "T6", "text": "p52", "entity_type": "Protein", "start": 110, "end": 110}, {"id": "T7", "text": "c-rel", "entity_type": "Protein", "start": 124, "end": 124}, {"id": "T8", "text": "NFATc2", "entity_type": "Protein", "start": 132, "end": 132}, {"id": "T9", "text": "NFATc1", "entity_type": "Protein", "start": 140, "end": 140}]}
{"doc_id": "PMC-1472690-14-Methods-06.txt", "sent_id": "", "tokens": ["The", "nuclear", "proteins", "were", "blotted", "onto", "a", "nitrocellulose", "membrane", "(", "Bio-Rad", ")", "."], "sentence": "The nuclear proteins were blotted onto a nitrocellulose membrane ( Bio-Rad ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1472690-14-Methods-06.txt", "sent_id": "", "tokens": ["After", "blocking", "with", "PBS", "/", "3", "%", "BSA", "(", "Fluka", ",", "Deisenhofen", ",", "Germany", ")", ",", "the", "blot", "was", "incubated", "overnight", "with", "the", "primary", "antibodies", "diluted", "1", ":", "2000", "in", "PBS", "/", "1", "%", "BSA", ",", "washed", "again", "and", "incubated", "with", "the", "alkaline", "phosphatase-conjugated", "secondary", "antibody", "(", "1", ":", "500", "in", "PBS", "/", "1", "%", "BSA", ")", "."], "sentence": "After blocking with PBS / 3 % BSA ( Fluka , Deisenhofen , Germany ) , the blot was incubated overnight with the primary antibodies diluted 1 : 2000 in PBS / 1 % BSA , washed again and incubated with the alkaline phosphatase-conjugated secondary antibody ( 1 : 500 in PBS / 1 % BSA ) .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMC-1472690-14-Methods-06.txt", "sent_id": "", "tokens": ["The", "blot", "was", "developed", "using", "the", "Vectastain", "(", "R", ")", "staining", "kit", "(", "Vector", "Laboratories", "Inc", ".", "Burlingame", ",", "CA", ",", "USA", ")", "."], "sentence": "The blot was developed using the Vectastain ( R ) staining kit ( Vector Laboratories Inc . Burlingame , CA , USA ) .", "event_mentions": [], "entity_mentions": []}
